(Q48898305)

English

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

scientific article published in February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

author name string

F Olivennes

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J Belaisch-Allart

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J C Emperaire

3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

H Dechaud

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

S Alvarez

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

L Moreau

6

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

B Nicollet

7

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

J R Zorn

8

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

P Bouchard

9

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

R Frydman

10

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Fertility and Sterility

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

73

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

314-320

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Control of the preovulatory Luteinizing Hormone surge by Gonadotropin-Releasing Hormone antagonists: prospects for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Synchronization of ovarian follicular waves with a gonadotropin-releasing hormone agonist to increase the precision of estrus in cattle: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Gene expression of gonadotropin-releasing hormone, but not its receptor, in human endometrium and decidua

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900524-5

7 January 2021

Identifiers

10.1016/S0015-0282(99)00524-5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10685535

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48898305&oldid=1612304210"